A detailed history of Terrapin Asset Management, LLC transactions in Seagen Inc. stock. As of the latest transaction made, Terrapin Asset Management, LLC holds 700 shares of SGEN stock, worth $0. This represents 0.17% of its overall portfolio holdings.

Number of Shares
700
Holding current value
$0
% of portfolio
0.17%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$191.51 - $216.16 $2.68 Million - $3.03 Million
14,000 New
14,000 $2.97 Billion

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Terrapin Asset Management, LLC Portfolio

Follow Terrapin Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Terrapin Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Terrapin Asset Management, LLC with notifications on news.